NR1H4 ameliorates Parkinson’s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPβ/NF-κB dependent manner
Article in International Immunopharmacology (December 2024)
The most recent citing publications are shown below. View all 74 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (December 2024)
Article in Brain Behavior & Immunity - Health (September 2024)
Article in International Journal of Molecular Sciences (August 2024)